FLT3 and acute myeloid leukemia: Moreover, CEBPA-dependent expression of Fms related receptor tyrosine kinase 3 (FLT3) renders acute myeloid leukemia cells vulnerable to ferroptosis upon inhibition of FLT3 [330], suggesting a therapeutic potential for targeting this pathway in acute myeloid leukemia treatment.